Two studies showcase molecular testing advancements in women's health, highlighting improved diagnosis and treatment for infectious diseases and cancer. The research reveals new insights into antimicrobial resistance, cancer recurrence risks, and tumor biology.
Researchers investigated the genetic mechanisms behind the emergence and disappearance of a vancomycin-resistant E. faecium clone in a hospital. The clone's success was attributed to a stable genome carrying key plasmids and accessory genes, which facilitated its persistence in the gut and on hospital surfaces.
Researchers develop flexible coating with microscopic cracks that amplify antibacterial power, killing 80% of bacteria within three hours. The coating, combined with electrical stimulation, creates an antimicrobial response that can be switched on when needed.
Researchers have successfully tested a 'living medicine' treatment in pigs, thinning biofilms of antibiotic-resistant Pseudomonas aeruginosa and reducing thickness by 40%. The treatment involves inhaling genetically modified bacteria designed to target biofilms on endotracheal tubes.
Researchers identified Nemuri peptides, derived from a sleep-inducing protein, that inhibit bacterial growth and protein synthesis. The peptides induce ribosomal condensation, reducing mobility and global protein synthesis, while showing low toxicity towards mammalian cells.
Researchers analyzed the bacteriophage protein Sgl PP7 and its interaction with MurJ, revealing a stabilizing effect on the protein. The study suggests that convergent evolution led to diverse inhibitory mechanisms, providing insights for designing new antibiotics.
A new study found that nearly a quarter of Americans misrepresent symptoms to get antibiotics, citing reasons such as feeling sick or needing to return to work. This behavior is dangerous and contributes to antimicrobial resistance, emphasizing the need for better communication strategies to ensure patients receive appropriate treatment.
A new study by the University of Gothenburg reveals that hospital sewers promote antibiotic-resistant bacteria, driven primarily by antibiotics such as ciprofloxacin and penicillin-like antibiotics. This finding highlights the need for targeted measures to mitigate the spread of antibiotic resistance.
Researchers have discovered a promising way to resensitize colistin-resistant bacteria to the antibiotic by combining it with L-arginine, an amino acid. The combination effectively kills strains of E. coli with the mcr-1 gene, which drives resistance, and shows potential as a new therapeutic approach
Fungi support antibiotic resistance genes and promote their survival and interactions, suggesting a novel approach to managing antibiotic resistance in agricultural waste. Reducing fungal activity increases removal of resistance genes, offering fresh insights into safer livestock waste management.
A study using metagenomic and qPCR approaches reveals a dominant resistome in Manila Bay, dominated by tetracycline and macrolide resistance, with clinically relevant ESBL genes detected at high levels. The study highlights the need for integrated clinical and environmental surveillance to inform One Health-oriented risk assessment.
Researchers propose a five-step decision-making framework to identify resistance risks early, refine promising drug candidates, and prevent costly failures. The framework groups antibiotic candidates into five main risk categories, helping developers decide which compounds to prioritize, redesign or pursue for more targeted applications.
Researchers at Umeå University discover a previously overlooked weakness in antibiotic-resistant bacteria that could help combat resistance. Disrupting the cell wall transport system makes these bacteria more susceptible to existing antibiotics.
Researchers at Aston University have engineered vegan honey alternatives with antimicrobial properties similar to mānuka honey, a natural product known for its antibacterial activity. The vegan honey formulations were tested against a culture of a highly drug-resistant bacterium, with promising results.
The fight against antimicrobial resistance is threatened by drug-resistant tuberculosis, highlighting the need for preventative frameworks and holistic control measures. New AI technologies and strategies are being developed to tackle the threat, including the use of genomic surveillance and streamlined clinical trial designs.
Researchers captured rapid chemical stages in penicillin formation, revealing the role of water molecules and enzyme movements in guiding the reaction. The study provides unprecedented insights into the mechanism of β-lactam antibiotic biosynthesis, shedding light on the complex chemistry involved in creating this crucial medicine.
A two-protein system in Pseudomonas aeruginosa detects iron both inside and outside the cell, rewiring the bacterium's metabolism and biofilm formation. The discovery suggests this system could be a target for new treatments for stubborn infections.
Staphylococcus aureus grows differently in milk and serum, with thicker membranes and increased pigment production in milk, making it more virulent and resistant to antibiotics. This unique relationship between milk lipids and bacterial severity suggests a need to adapt treatment protocols for mastitis infections.
Researchers have developed a new approach to fighting antibiotic-resistant bacteria using water, targeting their DNA with a special molecule called singlet oxygen. This method uses titanium dioxide crystals to transform normal oxygen molecules into singlet oxygen, which strips electrons away from bacterial DNA, destroying it.
A new study from the Max Planck Institute for the Science of Light reveals that physical processes in growing tumors and microbial biofilms play a crucial role in determining the optimal timing of treatment cycles. The researchers used a 'Real-To-Sim-To-Real' approach, combining microbial model systems and computer simulations, to show...
The University of Kansas has received $5.8 million in NIH funding to further its Chemical Biology of Infectious Disease center, which aims to develop targeted treatments for antibiotic-resistant pathogens. The center's collaborative approach will focus on protecting the beneficial microbiome while defeating resistance mechanisms.
The Blavatnik Foundation recognizes 9 young scientists for their exceptional research, advancing discoveries in life sciences, physical sciences & engineering. The 2026 honorees are advancing discoveries in areas such as autoimmune disease, cancer, and quantum technologies.
A new study by Danish researchers proposes a paradigm shift in understanding antibiotic resistance, highlighting the importance of environmental factors such as temperature, oxygen levels, and pH. This new knowledge may lead to more targeted treatments and better monitoring of resistance in humans, animals, and the environment.
A new review suggests that microplastics can act as mobile carriers for antibiotics and antibiotic resistance genes, creating hotspots where resistance can persist and spread. The review calls for integrated treatment methods to control microplastics, antibiotics, and resistance genes.
The Kreiswirth Lab has published three studies exploring bacterial resistance mechanisms, revealing how superbugs evade antibiotics and develop resistance. The research identifies new targets for treatment and offers insights into the underlying rules of bacterial survival.
Researchers used AI to screen a drug library for Streptococcus pneumoniae, identifying 11 compounds with antibacterial properties. Nine of these compounds inhibited the growth of the bacteria, including one that showed efficacy against drug-resistant strains.
A research team at IBEC has developed XpertBiofilm, a simple and low-cost device that replicates the flow and shear stress bacteria encounter in the human body. The device allows for the growth of biofilms under controlled conditions, enabling the study of their formation and antibiotic susceptibility.
A global study of over 700 bacterial genomes found that 87% of the bacteria from dogs and cats belonged to strains identified in humans. The study also revealed high levels of antibiotic resistance, with nearly half of animal-derived samples carrying genes resistant to clinically important antibiotics.
Researchers found that Staphylococcus aureus can adjust its inner workings in response to sulfur-containing compounds, switching between nutrient sources to keep growing. The bacteria can also use sulfur as armor to shield itself from toxic stresses.
A study of 13 drinking water sources in China's Poyang Lake region reveals that river-type sources carry higher risks from antibiotics and resistant bacteria than reservoir-type sources. The findings highlight the importance of considering water source type when designing monitoring and pollution-control strategies.
Researchers at the University of Osaka have identified a previously unknown mechanism that allows the bacterium Streptococcus pneumoniae to export the antibiotic fosfomycin. The discovery provides new clues to drug resistance and could lead to the development of more effective treatments for bacterial infections.
Microplastics act as pollutant shuttles, carrying chemicals, pathogens and antibiotic resistance genes through water, soil, food webs and environmental boundaries. A three-tiered framework identifies conditions for dominant ecological risks, highlighting the need for realistic risk assessment and unified global governance.
A 2025 analysis tracked 516,309 clinical bacterial isolates, revealing declining resistance in some major pathogens but worrying rebounds in others. The study highlights the need for sustained surveillance, antimicrobial stewardship, and stronger laboratory capacity to address evolving AMR patterns.
Researchers have identified an enzyme from cow gut that can break down bacterial biofilm components, making them more vulnerable to antibiotics. The enzyme, CRhAB, was found to be effective against two notorious pathogen groups, including Acinetobacter baumannii, which poses a significant threat in healthcare settings.
Researchers will investigate how mutation rates evolve across species, with potential insights into cancer progression and antibiotic resistance. The study aims to understand how reproductive modes alter mutation rates, which could inform broader understanding of evolution and adaptation.
Researchers examine bacterial persistence from multiple dimensions, highlighting its complex mechanisms and deep interactions with host-pathogen dynamics. Emerging strategies to eliminate persisters, such as phage-derived therapies and metabolic interventions, are also discussed.
A new study surveyed 1,475 people on their attitudes towards antibiotic course length, finding that shorter courses are as effective and safer for pneumonia, but many people prefer longer courses due to misinformation. The study suggests more nuanced communication between doctors and patients is needed.
Researchers have identified a naturally occurring gut molecule that strengthens chickens' immune response against bacterial infections. The compound, sodium butyrate, reprograms chicken immune cells to fight diseases without causing inflammation.
Researchers at Stanford University have developed an AI-powered tool called Evo 2 that can design novel phages to kill bacteria, including E. coli. The tool has already synthesized nearly 300 new phages and identified 16 exceptionally effective ones.
Penn researchers have developed a mobile microbiology laboratory allowing them to test water quality and track antimicrobial resistance in and around San Cristóbal in the Galápagos. The team identified sites of untreated wastewater contamination, including 'hot spots' of pollution around Puerto Baquerizo Moreno.
A China-wide study reveals that hospital characteristics do not significantly shape nearby water resistomes, with geography and broader urban pollution being the main factors influencing antibiotic resistance gene patterns. Proper wastewater treatment can substantially reduce the environmental release of resistance genes from hospitals.
Scientists at the University of Exeter have discovered two new mechanisms for how a well-established antibiotic works, which could lead to potential development of new antibiotic treatment. The study found that doxycycline targets the bacterial ribosome by blocking protein exit channels or reconfiguring it into an inactive state.
New research suggests that tire microplastics can create environmental hotspots that facilitate the persistence, transfer, and spread of antibiotic resistance genes through cities. The microplastics can develop dense microbial biofilms, release chemicals that select for resistant bacteria, and contribute to oxidative stress.
A €15 million EU-funded trial will investigate phage therapy as an alternative to antibiotics for recurrent urinary tract infections. Researchers from 13 countries, including Hebrew University and Hadassah Medical Center, will evaluate personalized bacteriophage therapy to treat antibiotic-resistant E. coli infections.
A new study reveals that industrial poultry farming has led to a 100-fold increase in Campylobacter movement, allowing strains to mix extensively in commercial poultry populations. This has resulted in more than 3.5 times as many gastroenteritis cases in the UK each year compared to other foodborne bacteria.
A study analyzing Chinese and global soil metagenomes found substantial declines in antimicrobial resistance genes after China implemented its AMR control plan. The research suggests a close association between soil resistomes and antimicrobial use patterns across human and animal sectors.
A new global database has been developed to map pathogens and antibiotic resistance risks in coastal waters, providing a practical tool for assessing biological risks. The Coastal Water Pathogen Database integrates shotgun metagenomic sequencing data from six coastal regions across three continents.
Researchers at the University of Washington School of Medicine discovered that environmental bacteria can acquire and transfer antibiotic resistance genes to disease-causing bacteria in human lungs. This mechanism, previously unknown, could lead to rapid development of extreme antibiotic resistance. The study highlights the potential f...
Researchers develop novel extracellular vesicle platform that makes bacteria more susceptible to polymyxins, enabling lower and safer treatment doses. The platform was shown to enhance bacterial killing and cause minimal toxicity in murine models.
Researchers have developed a new approach to combat superbugs by partnering existing antibiotics with molecular compounds called adjuvants. Using this method, they successfully restored the activity of vancomycin against drug-resistant E. faecium, a potentially life-threatening infection.
Researchers at St. Jude Children's Research Hospital discovered an RNA-based survival strategy that enables bacteria to tolerate antibiotics. The findings provide new insights into how persistent infections develop and could inform strategies to improve antibiotic effectiveness. Antibiotic tolerance allows bacteria to survive treatment...
A global monitoring platform reveals that antimicrobial resistance in children is rising, driven largely by Gram-negative bacteria. The platform forecasts that last-line carbapenem antibiotics will be highly resistant to these pathogens by 2035, posing a significant threat to children's health.
Researchers explored how AI and metabolic modeling can inform effective biocontrol strategies to combat antimicrobial resistance in built environments. Microbial biocontrol using 'good' microbes has shown promise, but inconsistent outcomes are due to various factors, including genetic differences and environmental stressors.
A study by Boston University researchers found that CARB-X-backed projects are nearly five times more likely to advance to clinical trials, while nonfunded projects had less than a quarter advancing. The nonprofit's support led to the award of 160 patents and increased odds of life-saving products reaching patients.
The DZIF-supported project PROTON aims to develop innovative agents against Staphylococcus aureus, a bacterial pathogen responsible for severe lung infections. The active agent, a pathoblocker, targets the toxin that destroys lung tissue and immune cells, reducing antibiotic resistance.
Researchers propose a three-part evolutionary framework for using bacteriophages to control antimicrobial resistance. The phage-host evolutionary triad suggests that phages can sometimes stabilize resistant bacteria instead of eliminating them, depending on environmental factors.
Researchers uncovered the genetic history of Acinetobacter baumannii, tracing its evolution over decades to identify key resistance traits and global spread. The study provides valuable insights for guiding policies on antibiotic use and combating this serious healthcare threat.
Scientists at Scripps Research have found that disabling a specific bacterial enzyme called SagA can restore the effect of vancomycin against resistant bacteria, making them treatable without needing a new antibiotic. This approach targets basic aspects of bacterial physiology and could overcome antibiotic resistance.
A new study uses AI to identify promising chemical compounds that could develop into effective antibiotics against multi-drug resistant Neisseria gonorrhoeae. The approach has the potential to address the growing crisis of antimicrobial resistance in this fast-evolving pathogen.
Researchers at the University of Notre Dame have discovered a key process for how gram-negative bacteria attach their outer membrane to the cell wall. The study found that protein PA2854 performs a chemical reaction linking the outer membrane to the cell wall, a crucial step in maintaining the bacterium's health.